Indeed, while we described efficient killing of wild-type p53/MYCN-driven tumors by MRE11 inhibition, ATR-CHK1 signaling seems to be especially essential for MYC-driven tumors in a p53-defective backgrounds34,35, which rarely occurs in MNA neuroblastoma. The gene discussed is TP53; the disease is neuroblastoma.